In this review, we analyse the performance of recently described tools for CRISPR/Cas9 guide RNA design, in particular, design tools that predict CRISPR/Cas9 activity. r What advances does it highlight?
Introduction
The development of designer nucleases has revolutionized the field of biotechnology by allowing site-specific DNA modifications with single-nucleotide resolution (Kim et al. 1996; Urnov et al. 2005; Miller et al. 2011; Mussolino et al. 2011) . In particular, the clustered regulatory interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system has been widely adopted as the designer nuclease of choice. The CRISPR/Cas9 system is a prokaryotic immune system present in bacteria and archaea that confers resistance to foreign DNA via a type of acquired immunity (Barrangou et al. 2007; Marraffini & Sontheimer, 2008) .
The crucial target-specific component of the CRISPR/Cas9 system is the guide RNA (gRNA), a short CRISPR/Cas9 guide RNA design single-stranded RNA sequence with an 80 nucleotide constant region and a short 20 nucleotide target-specific sequence that binds to a DNA target via Watson-Crick base pairing. By altering the sequence of the gRNA, it is possible to target specifically almost any 20 bp sequence in the human genome (Jinek et al. 2012; Cong et al. 2013; Mali et al. 2013) . However, early studies found that different gRNAs had different levels of DNA targeting, with some gRNAs capable of targeting 21% of alleles in a population of cells, whereas others achieved targeting rates of 77% (Cradick et al. 2013; Lee et al. 2017) . Several studies have attempted to elucidate rules for the rational design of highly active gRNAs (Doench et al. 2014; Chari et al. 2015; Moreno-Mateos et al. 2015; Wong et al. 2015; Xu et al. 2015) ; however, most design tools have not been experimentally validated for single-gene targeting. Here, we demonstrate that existing CRISPR/Cas9 design tools do not accurately predict the activity of single-gene-targeting gRNA sequences. Furthermore, we report that target site accessibility may influence Cas9 activity and suggest that future gRNA design algorithms need to incorporate locus-specific metrics.
Guide RNA design tools for predicting activity
The CRISPR/Cas9 system adopted from Streptococcus pyogenes (Spy) has been widely used in many genomeediting applications. By altering the short 20 nucleotide sequence, it is possible for SpyCas9 to target virtually any locus in the human genome. However, different gRNAs have varying degrees of activity. Although some gRNAs are capable of disrupting almost every target allele in a population of cells, others display no detectable activity. This discrepancy can lead to a significant amount of work in the search for a highly active gRNA design. This has led to the recent development of several CRISPR/Cas9 design tools. The studies underlying these design tools typically use high-throughput methods that screen >1000 gRNAs based on experimental data. The first high-throughput study analysed the activity of 1841 gRNAs in an effort to establish a common set of design rules that could be used for the rational design of highly active gRNAs (Doench et al. 2014) , resulting in the first publicly available design tool, sgRNA Designer. This was later updated with a new algorithm derived from machine learning-based predictive modelling (Doench et al. 2016) .
There are now several other design tools available (Ren et al. 2014; Chari et al. 2015; Moreno-Mateos et al. 2015; Wong et al. 2015; Xu et al. 2015) . However, many of these studies did not directly measure gRNA activity. For example, some studies determined gRNA efficiency by the loss of a surface marker, thereby counting only those cells that had undergone biallelic frameshift mutations (Doench et al. 2014) . These studies have also been conducted in a wide range of different organisms and tissues, including human cells, mouse cells, Caenorhabditis elegans, Drosophila melanogaster and Danio rerio. Although these algorithms display some significance within their own data sets (R 2 = 0.51 ± 0.12), when they are cross-validated with other data sets the predictive power diminishes significantly (R 2 = 0.23 ± 0.14; Haeussler et al. 2016) . To assess the ability of these publicly available design tools to predict the efficiency of gRNAs for single-gene-targeting experiments, we tested 198 gRNAs individually and compared their predicted score with the observed level of activity (Fig. 1A) . The best-performing algorithm had an R 2 of 0.3, demonstrating poor predictive capability (Fig. 1B) .
Locus effects on CRISPR/Cas9 activity
One thing these design algorithms have in common is heavy weighting of gRNA sequence features, e.g. which nucleotide is favoured at each position of highly active gRNAs. Other algorithms also include metrics for di-and tri-nucleotides. Some also include other metrics, such as duplex binding ( G) and the secondary structure or folding properties of the gRNA (Wong et al. 2015) , both of which are gRNA sequence dependent. We have begun to investigate the effect of non-sequence-dependent features in order to gain a better understanding of what influences CRISPR/Cas9 activity and to enable more accurate prediction of gRNAs before beginning any experimental work. In particular, we hypothesize that DNA accessibility and chromatin state play a role in the ability of CRISPR/Cas9 to generate a DNA double-strand break at the target locus. Indeed, recent reports have shown that DNA packaged as nucleosomes is protected from CRISPR/Cas9 cleavage in vitro (Hinz et al. 2015; Horlbeck et al. 2016; Isaac et al. 2016) . However, nucleosomes can be repositioned or restructured by ATP-dependent chromatin remodellers (Clapier & Cairns, 2009; Narlikar et al. 2013) , exposing the DNA target site to CRISPR/Cas9 in the process (Isaac et al. 2016) . However, the dynamic nature of nucleosomes makes it difficult to translate in vitro findings into a cellular context.
In order to study the effect on DNA accessibility in mammalian cells directly, we designed a series of gRNAs that target repetitive elements, thus removing any bias that might occur from using gRNAs that target different sequences. These gRNAs have between four and 20,000 target sites in the human genome. If chromatin state and DNA accessibility have no effect on CRISPR/Cas9 then the activity observed at each locus should be the same; however, if the activity differs significantly across different loci it would strongly suggest that DNA accessibility influences CRISPR/Cas9 activity. To query individual loci, we isolated individual target sites using barcoded primers unique to each locus. This limits the sites that can be analysed by deep sequencing to repeats that are shorter than 500 bp or that have sufficient sequence divergence. For one of these gRNAs, CTS 30, we successfully isolated 52 distinct genomic loci for deep sequencing. The level of CRISPR activity varied significantly across all 52 sites ( Fig. 2A and Supplementary Table S1 ), suggesting that CRISPR/Cas9 activity is influenced by locus-specific features independent of the target sequence. Previous work has shown that microhomologies were associated with 39.6% of all mutations induced by CRISPR/Cas9 gRNAs designed to target different sequences (Bae et al. 2014) . Interestingly, here we show that the nature of the mutations induced by a single gRNA (CTS 30) at multiple different loci was identical across all the active loci, suggesting that this sequence microhomology effect on the mutation spectrum following non-homologous end joining repair is not only heavily influenced by the target sequence but also dependent solely on the target sequence (Fig. 2B) . T01 T08 T15 T32 T40 T45 T52 T64 T80 T91 
Conclusion
The first-generation CRISPR gRNA design tools, although useful for quickly identifying gRNA target sites, do not accurately predict the cutting activity of Cas9 for single-locus gene modification in human cells. Our recent work focusing on the target locus as opposed to simply the target sequence suggests that there are non-sequence-based features that influence Cas9 activity. Indeed, recent in vitro studies demonstrating protection of DNA from Cas9 cleavage support our findings in human cells and suggest that DNA accessibility at the target locus could be a crucial factor. Further characterization of the locus features that influence CRISPR/Cas9 activity will improve the predictive power of new-generation gRNA design algorithms as well as shedding important light on the ability of Cas9 to recognize particular off-target loci. A better understanding of the target locus-specific effects will facilitate the studies of efficiency and specificity of CRISPR/Cas9-based genome editing across different cell types.
